Optimized cardiac output liberal fluid management strategy: Clinical Trials

1 active not recruiting, 1 recruiting. 2 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	2	Active not recruiting 1, Recruiting 1

Follow Optimized cardiac output liberal fluid management strategy: new trials by email Literature Review of Optimized cardiac output liberal fluid management strategy trials Research Report on Optimized cardiac output liberal fluid management strategy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Restrictive Fluid Management In Liver Transplantation (REFIL) Low splanchnic blood volume restrictive fluid management strategy, Phlebotomy, Optimized cardiac output liberal fluid management strategy - Liver Transplantation (LT), End-stage Liver Disease (ESLD)	Not applicable	Recruiting	Centre hospitalier de l'Université de Montréal (CHUM)	866	2026-02-15	2026-07-10
Restrictive Fluid Management In Liver Transplantation (REFIL) - Pilot Low splanchnic blood volume restrictive fluid management strategy, Optimized cardiac output liberal fluid management strategy, Phlebotomy - Liver Transplantation, End-stage Liver Disease (ESLD)	Not applicable	Active not recruiting	Centre hospitalier de l'Université de Montréal (CHUM)	138	2023-04-25	2026-06-16

Conditions studied

End Stage Liver Disease (2)  ·  Liver Diseases (2)

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM) (2)

Countries

Canada (2)

Top investigators

Francois Martin Carrier, MD (1)

NIH funding

2023 (1)